Comment on: Bivalirudin during thrombolysis with catheter‐directed tPA in a heparin‐refractory patient: A case report
Fuente:
Wiley Open Access
Salvato in:
| Autore principale: | Jennifer H. Han |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer
di: Gabriel Revon‐Riviere, et al.
Pubblicazione: (2024)
di: Gabriel Revon‐Riviere, et al.
Pubblicazione: (2024)
Successful avatrombopag salvage treatment in a pediatric patient with ANA‐positive refractory thrombocytopenia
di: Daniel Turudic, et al.
Pubblicazione: (2024)
di: Daniel Turudic, et al.
Pubblicazione: (2024)
A case report of myelodysplastic syndrome in a patient with PTPN11 ‐related Noonan syndrome
di: Christina Wiedl, et al.
Pubblicazione: (2024)
di: Christina Wiedl, et al.
Pubblicazione: (2024)
Results of a long‐term, prospective study on complications of central venous catheter in pediatric patients with hematologic‐oncologic diseases
di: Chiara Garonzi, et al.
Pubblicazione: (2024)
di: Chiara Garonzi, et al.
Pubblicazione: (2024)
Transformation of an abnormal karyotype to acute erythroid leukemia in a pediatric patient with Fanconi anemia: A case report
di: Lauren Hernandez, et al.
Pubblicazione: (2024)
di: Lauren Hernandez, et al.
Pubblicazione: (2024)
Boron neutron capture therapy prolongs survival in a patient with a recurrent malignant peripheral nerve sheath tumor—A case report
di: Yuko Watanabe, et al.
Pubblicazione: (2024)
di: Yuko Watanabe, et al.
Pubblicazione: (2024)
Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group
di: Jonathan Metts, et al.
Pubblicazione: (2024)
di: Jonathan Metts, et al.
Pubblicazione: (2024)
Reply to: Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
di: Jennifer Longoria, et al.
Pubblicazione: (2024)
di: Jennifer Longoria, et al.
Pubblicazione: (2024)
Outcomes of tunnelled cuffed centrally inserted central catheter removal: A retrospective cohort study
di: Eloise Borello, et al.
Pubblicazione: (2024)
di: Eloise Borello, et al.
Pubblicazione: (2024)
Acute megakaryoblastic leukemia associated with Sotos syndrome: A case report and review of evolving genetic associations
di: Maria Landherr, et al.
Pubblicazione: (2024)
di: Maria Landherr, et al.
Pubblicazione: (2024)
Comment on: Congenital dyserythropoietic anemia type IV with KLF1 E325K mutation: A new case with dysmorphic male genitalia. Report of a second case
di: Olha Dorosh, et al.
Pubblicazione: (2024)
di: Olha Dorosh, et al.
Pubblicazione: (2024)
Abnormal coronary hyperperfusion due to a giant hemangioendothelioma in fetal distress: A case report
di: Lulu Liang, et al.
Pubblicazione: (2024)
di: Lulu Liang, et al.
Pubblicazione: (2024)
Orbital T‐cell lymphoblastic lymphoma in children: A case report and review of literature
di: Rizine Mzikamanda, et al.
Pubblicazione: (2024)
di: Rizine Mzikamanda, et al.
Pubblicazione: (2024)
Epstein–Barr virus‐associated smooth muscle tumor in a female with ataxia telangiectasia: A case report
di: Beatrice Rivalta, et al.
Pubblicazione: (2024)
di: Beatrice Rivalta, et al.
Pubblicazione: (2024)
Incorporating innovative B‐cell targeting therapeutics into a combined‐modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B‐cell lymphoma
di: Yu‐Ju Chao, et al.
Pubblicazione: (2024)
di: Yu‐Ju Chao, et al.
Pubblicazione: (2024)
Neonatal hemolytic anemia due to the mother's rare RhD –/– phenotype: A case report
di: Saeed Soleimany, et al.
Pubblicazione: (2024)
di: Saeed Soleimany, et al.
Pubblicazione: (2024)
Treatment of pediatric refractory or relapsed Epstein–Barr virus‐associated hemophagocytic syndrome with PD‐1 inhibitors
di: Shu‐Yi Guo, et al.
Pubblicazione: (2024)
di: Shu‐Yi Guo, et al.
Pubblicazione: (2024)
The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single‐center experience
di: Andres F. Espinoza, et al.
Pubblicazione: (2024)
di: Andres F. Espinoza, et al.
Pubblicazione: (2024)
A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local‐REFoRMS)
di: Euan Ballantyne, et al.
Pubblicazione: (2024)
di: Euan Ballantyne, et al.
Pubblicazione: (2024)
Management of neonatal and infant aortic thrombosis: A single‐center case series
di: Ajibike Lapite, et al.
Pubblicazione: (2024)
di: Ajibike Lapite, et al.
Pubblicazione: (2024)
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)
di: Stefan S. Bielack, et al.
Pubblicazione: (2024)
di: Stefan S. Bielack, et al.
Pubblicazione: (2024)
Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
di: Roshni Dasgupta, et al.
Pubblicazione: (2024)
di: Roshni Dasgupta, et al.
Pubblicazione: (2024)
Time to diagnosis among young patients with cancer
di: Lena E. Winestone, et al.
Pubblicazione: (2024)
di: Lena E. Winestone, et al.
Pubblicazione: (2024)
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series
di: Ajibike Lapite, et al.
Pubblicazione: (2024)
di: Ajibike Lapite, et al.
Pubblicazione: (2024)
A severe case of delayed transfusion reaction in a patient with sickle cell disease while preparing for allogeneic stem cell transplant
di: Michelle Amit, et al.
Pubblicazione: (2024)
di: Michelle Amit, et al.
Pubblicazione: (2024)
Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma
di: Yun Zhang, et al.
Pubblicazione: (2024)
di: Yun Zhang, et al.
Pubblicazione: (2024)
Correction to: Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia
Pubblicazione: (2024)
Pubblicazione: (2024)
Late cognitive and adaptive outcomes of patients with neuroblastoma‐associated opsoclonus‐myoclonus‐ataxia‐syndrome: A report from the Children's Oncology Group
di: Prerna Kumar, et al.
Pubblicazione: (2024)
di: Prerna Kumar, et al.
Pubblicazione: (2024)
Outcomes of patients with intermediate‐risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531
di: Julie Voeller, et al.
Pubblicazione: (2024)
di: Julie Voeller, et al.
Pubblicazione: (2024)
Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia
di: Zsuzsanna Gaál, et al.
Pubblicazione: (2026)
di: Zsuzsanna Gaál, et al.
Pubblicazione: (2026)
Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531
di: Erin K. Barr, et al.
Pubblicazione: (2024)
di: Erin K. Barr, et al.
Pubblicazione: (2024)
Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series
di: Priya H. Marathe, et al.
Pubblicazione: (2024)
di: Priya H. Marathe, et al.
Pubblicazione: (2024)
Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia
di: Zefan Wang, et al.
Pubblicazione: (2026)
di: Zefan Wang, et al.
Pubblicazione: (2026)
Blinatumomab infusion interruptions in pediatric patients rarely lead to readmission
di: Jonathan Moody, et al.
Pubblicazione: (2024)
di: Jonathan Moody, et al.
Pubblicazione: (2024)
Trends in analgesia‐sedation of pediatric patients receiving I‐131 MIBG in the pediatric intensive care unit: A report from the Pediatric Health Information System database
di: Jordann Dhuse, et al.
Pubblicazione: (2024)
di: Jordann Dhuse, et al.
Pubblicazione: (2024)
Comment on: Intravenous iron for critically ill children. Comparison of three dose regimens
di: Salvador Payán‐Pernía, et al.
Pubblicazione: (2024)
di: Salvador Payán‐Pernía, et al.
Pubblicazione: (2024)
Real‐world experience of direct oral anticoagulant use in a single pediatric center
di: Gianna G. Valenti, et al.
Pubblicazione: (2024)
di: Gianna G. Valenti, et al.
Pubblicazione: (2024)
Comment on: Cost‐effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India
di: Manraj Singh Sra, et al.
Pubblicazione: (2024)
di: Manraj Singh Sra, et al.
Pubblicazione: (2024)
Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332
di: David P. Douglass, et al.
Pubblicazione: (2024)
di: David P. Douglass, et al.
Pubblicazione: (2024)
Comment on: Access to Legacy‐Oriented Interventions at End of Life for Pediatric Oncology Patients: A Decedent Cohort Review
di: Eman Zahra
Pubblicazione: (2024)
di: Eman Zahra
Pubblicazione: (2024)
Documenti analoghi
-
Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer
di: Gabriel Revon‐Riviere, et al.
Pubblicazione: (2024) -
Successful avatrombopag salvage treatment in a pediatric patient with ANA‐positive refractory thrombocytopenia
di: Daniel Turudic, et al.
Pubblicazione: (2024) -
A case report of myelodysplastic syndrome in a patient with PTPN11 ‐related Noonan syndrome
di: Christina Wiedl, et al.
Pubblicazione: (2024) -
Results of a long‐term, prospective study on complications of central venous catheter in pediatric patients with hematologic‐oncologic diseases
di: Chiara Garonzi, et al.
Pubblicazione: (2024) -
Transformation of an abnormal karyotype to acute erythroid leukemia in a pediatric patient with Fanconi anemia: A case report
di: Lauren Hernandez, et al.
Pubblicazione: (2024)